New pill tested to tame severe arthritis flares

NCT ID NCT07408024

Recruiting now Disease control Sponsor: Toll Biotech Co. Ltd. (Beijing) Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral medication called TollB-001 for adults with moderate to severe rheumatoid arthritis (RA) who haven't gotten enough relief from standard treatments. Participants will take the pill or a placebo daily for four weeks to see if it safely reduces arthritis symptoms and disease activity. The main goals are to check for side effects and see if the drug helps improve pain, stiffness, and swelling.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Affiliated Hospital of Inner Mongolia Medical University
RECRUITING

Hohhot, Inner Mongolia, China

Contact Phone: •••-•••-••••
Linfen Central Hospital
RECRUITING

Linfen, Shanxi, China

Contact Phone: •••-•••-••••
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
RECRUITING

Beijing, Beijing Municipality, 102206, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact
Pingxiang People's Hospital
RECRUITING

Pingxiang, Jiangxi, China

Contact Phone: •••-•••-••••
Puyang Oilfield General Hospital
RECRUITING

Puyang, Henan, China

Contact Phone: •••-•••-••••
The First Affiliated Hospital of Bengbu Medical College
RECRUITING

Bengbu, Anhui, China

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

RHEUMATOID ARTHRITIS (RA)